Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$4.08 -0.01 (-0.24%)
At close: Nov 10, 2026 · 4:00 PM EST

Vanda Pharmaceuticals (VNDA) Common Equity (2010 - 2026)

Updated

Vanda Pharmaceuticals' Common Equity came in at $199.86 million for Q3 2026, down 57.1% from $466 million a year earlier and down 9.2% from the prior quarter.

Analysis

Vanda Pharmaceuticals (VNDA) Common Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Vanda Pharmaceuticals' Common Equity was $327.19 million, down 39.2% from FY2024.

  • Common Equity carries a five-year compound annual growth rate of -6.3% (FY2020 to FY2025).
  • Going back by year, Common Equity was $538.55 million in FY2024 (-1.2%), $544.91 million in FY2023 (+3.4%), $527.2 million in FY2022 (+4.4%) and $504.93 million in FY2021 (+11.4%).
  • The Q3 2026 figure represents the lowest quarterly Common Equity since Q4 2017.
  • Year-over-year, Common Equity has declined for nine consecutive quarters, with an average decline of 28.4% over the last eight quarters.
  • The fastest year-over-year change in Common Equity over five years came in Q4 2021 (growth of 11.4%), and the weakest in Q3 2026 (a decline of 57.1%).
  • Business Quant data shows VNDA's Common Equity at $220.19 million (Q2 2026), $280.77 million (Q1 2026) and $327.19 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 40.27 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 81.53 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -4.58 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 44.95 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 50.37 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 13.04 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 89.30 Bn
10 Vanda Pharmaceuticals 245.19 Mn -531.49 Mn 65.66 Mn 199.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 199.86 Mn
Jun 30, 2026 220.19 Mn
Mar 31, 2026 280.77 Mn
Dec 31, 2025 327.19 Mn
Sep 30, 2025 466.00 Mn
Jun 30, 2025 486.33 Mn
Mar 31, 2025 511.42 Mn
Dec 31, 2024 538.55 Mn
Sep 30, 2024 541.22 Mn
Jun 30, 2024 542.52 Mn
Mar 31, 2024 544.00 Mn
Dec 31, 2023 544.91 Mn
Sep 30, 2023 543.10 Mn
Jun 30, 2023 539.90 Mn
Mar 31, 2023 535.74 Mn
Dec 31, 2022 527.20 Mn
Sep 30, 2022 515.66 Mn
Jun 30, 2022 508.55 Mn
Mar 31, 2022 502.12 Mn
Dec 31, 2021 504.93 Mn
API Access

Vanda Pharmaceuticals Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=VNDA&period=max&api_key=YOUR_API_KEY